Holdings
iShares Health Innovation Active ETF
As of Jul 31, 2026, iShares Health Innovation Active ETF reported 50 positions worth US$10.6M. Largest: Merck & Company, Inc., Gilead Sciences, Inc. and Johnson & Johnson. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Merck & Company, Inc. | 5,064 | US$659K | +1,444 | Jul 31, 2026 |
| Gilead Sciences, Inc. | 4,165 | US$542K | no change | Jul 31, 2026 |
| Johnson & Johnson | 1,955 | US$501K | −1,504 | Jul 31, 2026 |
| Edwards Lifesciences Corporation | 5,726 | US$493K | no change | Jul 31, 2026 |
| Thermo Fisher Scientific Inc | 812 | US$466K | +404 | Jul 31, 2026 |
| Charles River Laboratories International, Inc. | 1,783 | US$415K | no change | Jul 31, 2026 |
| Danaher Corporation | 2,077 | US$405K | +679 | Jul 31, 2026 |
| Biogen Inc. | 1,935 | US$393K | no change | Jul 31, 2026 |
| Waters Corporation | 1,035 | US$391K | no change | Jul 31, 2026 |
| Mettler-toledo International, Inc. | 274 | US$388K | +29 | Jul 31, 2026 |